Annual EBITDA
-$4.21 M
+$9.51 M+69.31%
01 December 2023
Summary:
Petros Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization is currently -$4.21 million, with the most recent change of +$9.51 million (+69.31%) on 01 December 2023. During the last 3 years, it has risen by +$8.09 million (+65.76%). PTPI annual EBITDA is now -142.06% below its all-time high of -$1.74 million, reached on 31 December 2021.PTPI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$1.29 M
-$1.50 M-724.37%
01 September 2024
Summary:
Petros Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization is currently -$1.29 million, with the most recent change of -$1.50 million (-724.37%) on 01 September 2024. Over the past year, it has dropped by -$2.57 million (-200.98%). PTPI quarterly EBITDA is now -126.34% below its all-time high of $4.91 million, reached on 31 March 2021.PTPI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$1.09 M
+$2.26 M+67.42%
01 September 2024
Summary:
Petros Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization is currently -$1.09 million, with the most recent change of +$2.26 million (+67.42%) on 01 September 2024. Over the past year, it has increased by +$3.12 million (+74.02%). PTPI TTM EBITDA is now -354.49% below its all-time high of $430.00 thousand, reached on 30 September 2021.PTPI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTPI EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -201.0% | +74.0% |
| 3 y3 years | +65.8% | -1365.8% | -354.5% |
| 5 y5 years | - | - | - |
PTPI EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -142.1% | +69.3% | -184.0% | +89.3% | -354.5% | +93.6% |
| 5 y | 5 years | -142.1% | +70.0% | -126.3% | +89.3% | -354.5% | +93.6% |
| alltime | all time | -142.1% | +70.0% | -126.3% | +89.3% | -354.5% | +93.6% |
Petros Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.29 M(-724.4%) | -$1.09 M(-67.4%) |
| June 2024 | - | $207.20 K(-116.1%) | -$3.36 M(-34.4%) |
| Mar 2024 | - | -$1.29 M(-200.6%) | -$5.12 M(+21.5%) |
| Dec 2023 | -$4.21 M(-69.3%) | $1.28 M(-136.0%) | -$4.21 M(-50.7%) |
| Sept 2023 | - | -$3.56 M(+129.4%) | -$8.55 M(-50.0%) |
| June 2023 | - | -$1.55 M(+303.2%) | -$17.10 M(+9.3%) |
| Mar 2023 | - | -$384.60 K(-87.4%) | -$15.65 M(+14.0%) |
| Dec 2022 | -$13.73 M | -$3.05 M(-74.8%) | -$13.73 M(-20.0%) |
| Sept 2022 | - | -$12.11 M(>+9900.0%) | -$17.16 M(+246.7%) |
| June 2022 | - | -$100.60 K(-106.5%) | -$4.95 M(-3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.54 M(-123.7%) | -$5.11 M(+193.8%) |
| Dec 2021 | -$1.74 M(-85.9%) | -$6.49 M(-6452.0%) | -$1.74 M(-504.7%) |
| Sept 2021 | - | $102.20 K(-139.0%) | $430.00 K(-223.8%) |
| June 2021 | - | -$261.90 K(-105.3%) | -$347.30 K(-89.9%) |
| Mar 2021 | - | $4.91 M(-213.6%) | -$3.44 M(-72.0%) |
| Dec 2020 | -$12.30 M(-12.3%) | -$4.32 M(+540.1%) | -$12.30 M(+54.2%) |
| Sept 2020 | - | -$675.10 K(-79.9%) | -$7.98 M(+9.2%) |
| June 2020 | - | -$3.36 M(-15.0%) | -$7.30 M(+85.0%) |
| Mar 2020 | - | -$3.95 M | -$3.95 M |
| Dec 2019 | -$14.02 M | - | - |
FAQ
- What is Petros Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Petros Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals TTM EBITDA year-on-year change?
What is Petros Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of PTPI is -$4.21 M
What is the all time high annual EBITDA for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$1.74 M
What is Petros Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of PTPI is -$1.29 M
What is the all time high quarterly EBITDA for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is $4.91 M
What is Petros Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, PTPI quarterly earnings before interest, taxes, depreciation & amortization has changed by -$2.57 M (-200.98%)
What is Petros Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of PTPI is -$1.09 M
What is the all time high TTM EBITDA for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is $430.00 K
What is Petros Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, PTPI TTM earnings before interest, taxes, depreciation & amortization has changed by +$3.12 M (+74.02%)